Pricing Log in Create free account

MetaVia Inc. (MTVA) vs VistaGen Therapeutics, Inc. (VTGN)

MetaVia Inc. and VistaGen Therapeutics, Inc. are both Biotechnology companies. MetaVia Inc. and VistaGen Therapeutics, Inc. are of similar size ($9.5M and $9.0M). MetaVia Inc. has the higher net margin (0.00% vs −2,703.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, MetaVia Inc. leads on 8 and VistaGen Therapeutics, Inc. on 4.

Valuation

Metric MTVA VTGN Biotechnology median
P/E n/m n/m 8.50
P/S n/m 3.44 9.71
P/B 1.10 0.35 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.09 0.21 0.64
EV/Sales n/m (5.93) 9.21
Earnings yield (178.24%) (830.00%) (33.15%)
Free cash flow yield (211.89%) (726.47%) (25.50%)

Profitability

Metric MTVA VTGN Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (2,785.69%) 0.00%
Net margin 0.00% (2,703.72%) 0.00%
Free cash flow margin 0.00% (2,490.88%) 0.00%
Return on equity (175.68%) (166.46%) (56.36%)
Return on assets (91.06%) (129.22%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MTVA VTGN Biotechnology median
Revenue growth (TTM) — 287.15% 6.02%
EPS growth (last fiscal year) 81.23% (9.58%) 30.26%
Revenue growth, 5-year CAGR — 3.10% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MTVA VTGN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.06 3.07 4.72
Net debt to EBITDA 0.75 0.63 0.96

Dividend

Metric MTVA VTGN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric MTVA VTGN Biotechnology median
Market cap 9.03m 9.45m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack